Skip to main content
SpringerLink
Log in

Fortschritte der fibrinolytischen Therapie

  • Published:
Blut Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Abe T.: Influence of pyridin-monocarbonic acids and some other drugs on fibrinolysis: p. 413, 8. internat. Congr. Haemat., Tokio 1960.

  2. Abe T., A. Sato: Inhibitory activity of epsilon amino caproic acid on fibrinolysis. p. 270, 7. Congr. Europ. Soc. Haemat. 1959.

  3. Adamkiewicz V. W., W. B. Rice, J. D. McColl: Antiphlogistic effect of trypsin in normal and adrenalectomized rats. Canad. J. Biochem. Physiol. 33, 332 (1955).

    Google Scholar 

  4. Agostino D., C. E. Grossi, E. E. Cliffton: Effect of human fibrinolysin on hepatic metastasis in inocculated colon carcinoma of rats. Annals Surg. 153, 365 (1961).

    Google Scholar 

  5. Alkjaersig N.: Laboratory control of the thrombolytic state. Conference on thrombolytic agents, Chicago 1960, 136–145.

  6. Alkjaersig N., A. P. Fletcher, S. Sherry: The mechanism of clot dissolution by plasmin. J. Clin. Invest. 38, 1086 (1959).

    Google Scholar 

  7. Alkjaersig N., A. P. Fletcher, S. Sherry: ε-Amino caproic acid: an inhibitor of plasminogen activation. J. Biol. Chem. 234, 832 (1959).

    Google Scholar 

  8. Ambrus J. L., C. M. Ambrus, S. E. Sokal, G. Marcus, N. Back, L. Stutzman, D. Razis, C. A. Roß, B. H. Smith, A. G. Rekate, G. L. Collins, D. L. Kline, J. B. Fishman: Clinical Pharmacology of various types of fibrinolysin enzyme preparations. Am. J. Card. 6, 462 (1960).

    Google Scholar 

  9. Ambrus C. M., N. Back, J. L. Ambrus: Fibrinolytic effect of plasmin-antiplasmin complex. Fed. Proc. 19, 58 (1960).

    Google Scholar 

  10. Ambrus C. M., G. Markus: Plasmin antiplasmin complex as a reservoir of fibrinolytic enzyme. Am. J. physiol. 199, 491 (1960).

    Google Scholar 

  11. Amery A., J. Vermylen, H. Maes, M. Verstraete: Enhancing the fibrinolytic activity in human blood by occlusion of blood vessels. I. The appearance of the phenomenon. Thromb. Diath. haem. im Druck.

  12. Anlyan W. G., H. L. Deaton, D. Silver, J. L. Webster, E. K. Spada: Experiences with plasmin in clinical and experimental peripheral vascular occlusive disease. Am. J. Card. 6, 507 (1960).

    Google Scholar 

  13. Anlyan W. G., D. Silcer, H. L. Deaton, L. Fort, J. L. Webster: Fibrinolytic agents in surgical practice. J. A. M. A. 175, 290 (1961).

    Google Scholar 

  14. Astrup T., Fibrinolysis in the organism. Blood 11, 781 (1956).

    Google Scholar 

  15. Astrup T.: Neuere Aspekte in der Blutgerinnung und der Fibrinolyse und ihre Beziehungen zur Coronarthrombose und Coronarsclerose. Wiener Z. Inn. Med. 39, 373 (1958).

    Google Scholar 

  16. Back N., J. L. Ambrus, C. L. Simpson, S. Shulman: Study on the effect of streprokinase activated plasmin on clots in various stages of organisation. J. clin. Invest. 37, 864 (1958).

    Google Scholar 

  17. Bang N. U.: Electron microscopy of normal and abnormal clot structure. 88 Europ. Haemat. Kongr. 1961.

  18. Baumgarten W., K. B. McCall, C. M. Ambrus, R. Pennel: Assay techniques: The problems of correlation with treatment results. Am. J. Card. 6, 447 (1960).

    Google Scholar 

  19. Beller F. K., G. Schumacher: Über die Kombination von fibrinolytischer und antikoagulativer Therapie. Dtsch. Med. Wschr. 82, 2029 (1957).

    Google Scholar 

  20. Beller F. K., D. Sellin: Fibrinolyse-Aktivierung durch eine Kombination von Nicotinsäure und Heparin. Arzneimittelforschung, 10, 758 (1960).

    Google Scholar 

  21. Blix S.: Antibodies after streptokinase treatment and their importance for repeated fibrinolytic therapy. Acta. med. Scand. 170, 201 (1961).

    Google Scholar 

  22. Bolton H. E., F. A. Tapia, M. Cabral, R. Riera, M. S. Mazel: Acute coronary thrombus and fibrinolysis. J. A. M. A. 175, 307 (1961).

    Google Scholar 

  23. Boucck R. J., W. G. Murphy, L. S. Sommer, I. J. Voudoukis: Treatment of coronary thrombosis by perfusion of the coronary arteries with thrombolytic agents. Am. J. Card. 6, 525 (1960).

    Google Scholar 

  24. Boyles P. W.: Thrombollysis in dogs with human fibrinolysin. J. Lab. a. clin. Med. 54, 551 (1959).

    Google Scholar 

  25. Boyles P. W.: Procedures and therapy in coronary thrombosis. J. Am. Med. As. 175, 279 (1961).

    Google Scholar 

  26. Boyles P. W., W. H. Meyer, L. Gong: Arterial clot lysis with segmental prefusion of fibrinolysin. Clin. Res. 8, 52 (1960).

    Google Scholar 

  27. Boyles P. W., W. Meyer, J. Graff, C. C. Ashlev, R. C. Ripic: Comparative effectiveness of intravenous and intra-arterial fibrinolysin therapy. Am. J. Card. 6, 439 (1960).

    Google Scholar 

  28. Caroll B. J.: Clinical observations in the treatment of phlebothrombosis with fibrinolysin. Angiology 10, 308 (1959).

    Google Scholar 

  29. Celander D. R., M. M. Guest: Factors influencing the susceptibility of fibrin and fibrinogen to proteolysis by fibrinolysin. Arch. Biochem. Biophys. 72, 176 (1957).

    Google Scholar 

  30. Celander D. R., M. M. Guest: The biochemistry and physiology of urokinase. Am. J. Card. 6, 409 (1960).

    Google Scholar 

  31. Clark R., E. E. Cliffton: Treatment of cerebral thrombosis with fibrinolysin: Systemic and local. Am. J. Card. 6, 546 (1960).

    Google Scholar 

  32. Cliffton E. E.: Review of experience with clot lysing agents. Am. J. Card. 6, 476 (1960).

    Google Scholar 

  33. Cochran B., E. B. Whitney, A. G. Ware: Induced and spontaneous fibrinolysis in man. Clin. Res. 6, 47 (1958).

    Google Scholar 

  34. Cohen H., M. Graff, W. Kleinberg: Inhibition of dextran edema by proteolytic enzymes. Proc. Soc. Exper. Biol. Med. 88, 517 (1955).

    Google Scholar 

  35. Copley A. L.: Fibrinolysis and arteriosclerosis. Lancet 1957, I, 102.

    Google Scholar 

  36. Creech O. L., M. E. Bakey, W. H. Amspacher, D. E. Mahaffey: The intrathroracic use of streptokinasestreptodornase. Annals. Surg. 19, 128 (1953).

    Google Scholar 

  37. Deaton H. L., W. G. Anlyan, D. Silver, J. Webster: Thrombosis prevention and treatment. Surg. 49, 130 (1961).

    Google Scholar 

  38. Deutsch E.: Blutgerinnungsfaktoren, Wien, Deuticke 1955, S. 179ff.

  39. Deutsch E.: Zum Thema Fibrinolyse. Schweiz. med. Wschr. 90, 1252 (1960).

    Google Scholar 

  40. Deutsch E., P. Elsner: Pyrogens as thrombolytic agents. Clinical and experimental studies. Am. J. Card. 6, 420 (1960).

    Google Scholar 

  41. Deutsch, E., P. Elsner, M. Fischer: Medikamentös induzierte Fibrinolyse. Wien. Z. Inn. Med. 4, 457 (1960).

    Google Scholar 

  42. Deutsch E., P. Elsner, I. Marschner: The mechanism of fibrinolysis induced by bacterial pyrogens. Thromb. Diath. haem. 3, 286 (1959).

    Google Scholar 

  43. Deutsch E., M. Fischer: Die Wirkung intravenös applizierter Streptokinase auf Fibrinolyse und Blutgerinnung. Thromb. Diath. haem. 4, 482 (1960).

    Google Scholar 

  44. Deutsch E., M. Fischer, Medikamentös induzierte Fibrinolyse. Verh. Dtsch. Ges. Inn. Med. 66, 1012 (1960).

    Google Scholar 

  45. Deutsch E., M. Fischer, A. Stacher: Zur praktischen Durchführung der Fibrinolysetherapie mit Enzympräparaten. Folia Haemat. 6, 310 (1961).

    Google Scholar 

  46. Donaldson V. H.: Effect of Plasmin in vitro on clotting factors in plasma. J. Lab. a. clin. Med. 56, 644 (1960).

    Google Scholar 

  47. Duprez A., A. Dumont: La streptokinase en chirurgie thoracique, le hémothorax après pneumonectomie totale et après creation d'un pneumothorax extrapleural. Presse medical 59, 1573 (1951).

    Google Scholar 

  48. Elfving G., M. Turunen: Klinische Erfahrungen mit Streptokinase und Streptodornase. Ann. Chir. et gyn. Fenniae 41, 143 (1952).

    Google Scholar 

  49. Elsner P., E. Deutsch, A. Kratochwil: Untersuchungen über die Pyrexalfibrinolyse. Wien klin. Wschr. 71, 586 (1959).

    Google Scholar 

  50. Engel E., J. Brichant, J. P. Delmez, A. Vernet, A. M. Riondel: Influence de la pyretotherapie sur la réponse surrénalienne et l'activité fibrinolytique du plasma chez l'homme. Helvet. med. Acta 24, 459 (1957).

    Google Scholar 

  51. Engler H. S., P. Christopher, W. H. Moretz: The use of fibrinolysin in the preventions of thrombus formation in small artery anastomoses. Angiology 10, 259 (1959).

    Google Scholar 

  52. Evans J. A., M. I. Smedal: Clinical experiences with fibrinolysin therapy. Angiology 10, 311 (1959).

    Google Scholar 

  53. Fearnley G. R., R. Lackner: The fibrinolytic activity of normal blood. Brit. J. hemat. 1, 189 (1955).

    Google Scholar 

  54. Fillmore A. J.: Use of fibrinolysin in nonhospitalized patients. Angiology 12, 174 (1961).

    Google Scholar 

  55. Finnerty J. J.: The use of streptokinase-streptodornase in the treatment of thoracic empycma. Surg. etc. 97, 220 (1953).

    Google Scholar 

  56. Fischbacher W.: Beitrag zur Fibrinolyse. Versuche in vivo und in vitro mit den Stoffen: Streptokinase (Varidase-Lederlc), Plasmin (Thrombolysin Merck Sharp & Dohme) Plasminogen (Ortho). Pyrexal (Wander), ε-Aminocapronsäure. Diss. Zürich 1960.

  57. Fleischhacker H.: Moglichkeiten der Thrombosetherapic. Akad. ärztl. Fortbild. Berlin. 11, 10 (1961).

    Google Scholar 

  58. Fletcher A. P.: Intrathecal fibrinolysis with streptokinase in tuberculose meningitis. J. clin. Invest. 33, 69 (1954).

    Google Scholar 

  59. Fletcher A. P., N. Alkjaersig, T. Astrup, E. Deutsch, W. Fischbacher, A. Johnson, I. M. Nilsson: Panel über Kontrolle der fibrinolytischen Therapic. 8. Kongr. Europ. Ges. Haemat., Wien 1961.

  60. Fletcher A. P., N. Alkjacrsig, S. Sherry: The clearance of heterologous protein from the circulation of normal and immunized man. J. Clin. Invest. 37, 1306 (1958).

    Google Scholar 

  61. Fletcher A. P., N. Aljaersig, S. Sherry: Pathogenesis of the haemorrhagic diathesis developing during fibrinolytic states. The significance of defective fibrin polymerisation. J. clin. Invest. 38, 1005 (1959).

    Google Scholar 

  62. Fletcher A. P., N. Alkjaersig, S. Sherry: The maintenence of a sustained thrombolytic state in man. I. Induction and effect. J. clin. Invest. 38, 1096 (1959).

    Google Scholar 

  63. Fletcher A. P., N. Alkjacrsig, S. Sherry: Assay of thrombolytic (fibrinolytic) mixtures intended for therapeutic use. J. Lab. a. clin. Med. 57, 620 (1961).

    Google Scholar 

  64. Fletcher A. P., S. Sherry: Thrombolytic (fibrinolytic) therapy for coronary heart disease. Circ. 22, 619 (1960).

    Google Scholar 

  65. Fletcher A. P., S. Sherry, N. Alkjaersig, F. E. Smyrniotis, S. Jick, II: clinical observations on patients with myocardial infarction and other thromboembolic disorders. J. clin. Invest. 38, 1111 (1959).

    Google Scholar 

  66. Freiman A. H., N. U. Bang, P. Ruegsegger, I. Nydick, E. E. Cliffton: The formation of peripheral clots in the hypercoagulable state and their dissolution by fibrinolysin. Clin. Res. 6, 203 (1958).

    Google Scholar 

  67. Gorden S., F. B. Ablondi: The effect of streptococcal enzymes and other agents on experimental inflammation. Ann. N. Y. Acad Sci. 68, 89 (1957).

    Google Scholar 

  68. Gospe S. W., A. Zipser, B. J. Weil, A. L. Finkle: Fibrinolytic dissolution of renal pelvic clot post partum. New Engl. J. Med. 263, 957 (1960).

    Google Scholar 

  69. Groß R., W. Hartl, G. Kloß, B. Rahn: Thrombolyse durch Infusionen hochgereinigter Streptokinase. Dtsch. med. Wschr. 85, 2129, 2141, 2147 (1960).

    Google Scholar 

  70. Grossi, C. E., E. E. Cliffton: D. Cannamela: The lysis of intravascular thrombi in rabbits with human plasmin (Fibrinolysin). Blood 9, 310 (1954).

    Google Scholar 

  71. Halse Th.: Ergänzender Beitrag zur Aktivierung der Fibrinolyse des nativen Plasmakoagulums durch Heparin. Arch. intern. Pharmacodyn. 86, 168 (1951).

    Google Scholar 

  72. Halse Th.: Enzymologie der spontanen und therapeutisch induzierten Fibrinolyse. Z. Vi. Ho. F.-Forch 11, 47 (1960).

    Google Scholar 

  73. Hardin C. A., W. Leo: Treatment of clotted haemothorax with fibrinolysin. Dis. Chest. 36, 37 (1959).

    Google Scholar 

  74. Hecker S. P., H. C. Zweng: Central retinal artery occlusion treated with plasmin. J. A. M. A. 176, 1067 (1961).

    Google Scholar 

  75. Henseler A., F. Lambertz: Zur Behandlung des Pneumolysenhämatoms mit Bistreptase. Beitr. klin. Tbk. 108, 387 (1953).

    Google Scholar 

  76. Herndorn R. M., J. Meyer, J. E. Johnson, J. Landers: Treatment of cerebro-vascular thrombosis with fibrinolysin. Am. J. Card. 6, 540 (1960).

    Google Scholar 

  77. Hoppe R.: Über Erfolge mit Streptokinase und Streptodornase. Dtsch. med. Wschr. 77, 123 (1952).

    Google Scholar 

  78. Hörder M. H., B. Kickhöfen: Vergleichende Untersuchungen über den Nachweis der Fibrinolyse nach Injektion eines bakteriellen Lipolpolysaccharids (Pyrexal). Acta haemat. 17, 321 (1957).

    Google Scholar 

  79. Hörder M. H., B. Kickhöfen, F. Wendt: Aktivierung der Fibrinolyse beim Menschen durch ein bakterielles Pyrogen. Der Einfluß von Phenylbutazon und Heparin auf Fibrinolyse, Blutgerinnung und Fieberreaktion. Klin. Wschr. 36, 164 (1958).

    Google Scholar 

  80. Howden G. D.: The succesful treatment of a case of central retinal vein thrombosis with intravenous fibrinolysin. Canad. Med. Ass. J. 81, 382 (1959).

    Google Scholar 

  81. Hume M.: The radioactive experimental pulmonary embolus as a laboratory means of evaluating fibrinolytic enzymes. Conference on thrombolytic agents, Chicago 1961.

  82. Innerfield I.: Physiological and clinical effects of buccally given proteases. J. A. M. A. 170, 925 (1959).

    Google Scholar 

  83. Johnson A. J., W. R. McCarty: The lysis of artificially induceds intravascular clots in man by i. v. infusion of streptokinase. J. clin. Invest. 37, 905 (1958).

    Google Scholar 

  84. Johnson A. J., W. R. McCarty: The lysis of artificially induced intravascular clots in man by i. v. infusion of streptokinase. J. clin. Invest. 38, 1627 (1959).

    Google Scholar 

  85. Johnson A. J., W. McCarty: Some aspects of the mechanism of thrombolysis. Thromb. Diath haem. 5, 391 (1961).

    Google Scholar 

  86. Johnson A. J., W. Tillet: The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system. J. exper. Med. 95, 449 (1952).

    Google Scholar 

  87. Kahn P., A. Stacher: Zur Bestimmung der therapeutisch notwendigen Streptokinasedosis. Wien klin. Wschr. im Druck.

  88. Kahn P., A. Stacher, E. Deutsch: Thrombolytische Therapie mit hochgereinigter Streptokinase. Wien, klin. Wschr. 73, 677 (1961).

    Google Scholar 

  89. Kaulla K. N.: Intravenous protein-free pyrogen. A powerful fibrinolytic agent in man. Circulation 17, 187 (1958).

    Google Scholar 

  90. Kaulla K. N.: Methods for preparation of purified human thromboplastin and fibrinolysokinase from urine. Acta haemat. 16, 315 (1956).

    Google Scholar 

  91. Kaulla K. N.: Fibrinolytic activity induced by synthetic compounds. In vitro studies with human plasma. 8. Europ. Kongr. Haemat. Wien 1961.

  92. Kaulla K. N., T. S. McDonald: The effect of heparin on components of the human fibrinolytic system. Blood 13, 811 (1958).

    Google Scholar 

  93. Kaulla K. N., T. S. McDonald, G. H. Taylor: The effect of heparin on fibrinolysis. J. Lab. clin. Med. 48, 952 (1956).

    Google Scholar 

  94. Kickhöfen P., F. E. Struwe, B. Bramesfeld, O. Westphal: Über einige Beobachtungen am Uropepsinogen und am Plasminogen Activator des menschlichen Urins. Biochem. Z. 330, 467 (1958).

    Google Scholar 

  95. Kline D. L., J. B. Fishman Plasmins: The humoral protease. Ann. N. Y. Acad. Sci. 68, 25 (1957).

    Google Scholar 

  96. Kline D. L., J. P. Fishman: Purification of components of the plasmin system. Am. J. Card. 6, 387 (1960).

    Google Scholar 

  97. Knight V., R. C. Hardy, J. Negrin: Meningitis due to Pseudomonas acruginosa. Intrathecal treatment with streptokinase and streptodornase and i. m. and intrathecal treatment with neomycin. J. A. M. A. 149, 1395 (1952).

    Google Scholar 

  98. Kowalski E.: Fibrinogen derived inhibitors of blood coagulation. Thromb. Diath. haem. 1960. Suppl. ad. Vol IV S. 211–223.

    Google Scholar 

  99. Levy J., P. Parent, A. Nicolas, R. Merger: Fibrinolyse aigue chez une accouchée. Gue'rison par l'inhibiteur de Kunitz. Press méd. 69, 849 (1961).

    Google Scholar 

  100. Malmström, B. G., Norberg, U. Toots: Streptokinase treatment of myocardial infarction. 8. Europ. Kongr. Haemat. Wien 1961.

  101. Marchal G., M. Samama, J. Mirabel, Y. Vaysse: Fibrinolyse cataclysmique au cours d'un traitment chirurgical d'une tétralogie du Fallot en circulation extra-corporeelle. Résultates encourageants in vitro d'un agent antifibrinolytique. Sem. Hôp. Par. 36, 1994 (1960).

    Google Scholar 

  102. Martin G. J.: Anti-inflammatory effect of trypsin. Ann. N. Y. Acad. Sci. 68, 70 (1957).

    Google Scholar 

  103. Meneghini P.: Sul meccanismo d'azione della terapia anticoagulante e fibrinolitica. Atti del primo simposio sui problemi attinenti alla coagulazione del sangue Genova, 1953.

  104. Meneghini P.: Le traitement fibrinolytique des thromboses et des embolies. Thrombose und Embolie, Basel 1954, p. 873.

    Google Scholar 

  105. Meneghini P.: Fibrinolytictreatment of thrombo-embolicdisease with purified bacterial pyrogens. Acta haemat. 19, 65 (1958).

    Google Scholar 

  106. Miller J. M.: The antiinflammatory effects of i. m. streptokinase. Ann. N. Y. Acad. Sci. 68, 185 (1957).

    Google Scholar 

  107. Moser K., G. C. Hajjar: The combined use of fibrinolytic and anticoagulant agents: Laboratory and clinical considerations. Am. J. Card. 6, 496 (1960).

    Google Scholar 

  108. Niewiarowski S., E. Kowalski: Antithrombin formation during proteolysis offibrinogen. Proc. 6th. Congr. Europ. Soc. Haemat. Karger 1958p.560.

  109. Nilsson I. M., A. Sjoerdsma, J. Waldenström: Antifibrinolytic activity and metabolisms of ε-amino carproic acid in man. Lancet 1960, I, 1322.

    Google Scholar 

  110. Norman Ph. S.: Some aspects of the chemistry of plasmin and its inhibitors. Am. J. Card. 6, 390 (1960).

    Google Scholar 

  111. Olesen E. S.: Fibrinolytics activity derived from guinea pig serum by peptone. Acta phys. Scand. 41, 187 (1957).

    Google Scholar 

  112. Olesen E. S.: Fibrinolytic activity produced in guinea pig serum by some human fluids and hyaluronic acid. Scand. J. Lab. clin. Invest. 13, 36 (1961).

    Google Scholar 

  113. Olow B., I. M. Nilsson: Streptokinase induced fibrinolysis in man. 8. Europ. Kongr. Haemat. Wien 1961.

  114. Parsons W. B.: Experiences with in vivo production of fibrinolysis following parenteral administration of nicotinic acid in humans. Circ 20, 989 (1959).

    Google Scholar 

  115. Randolph W. A., H. M. Starling: Fibrinolysin therapy in thrombo-embolic disease. Angiology 12, 179 (1961).

    Google Scholar 

  116. Ruegsegger P., I. Nydick, R. Abarquez, F. Reichel, E. E. Cliffton: Effect of fibrinolytic therapy upon the pathophysiology of myocardial infarction. Am. J. Card. 6, 519 (1960).

    Google Scholar 

  117. Ruegsegger P., I. Nydick, J. S. LaDue, E. E. Cliffton: The influence of plasmin upon experimental pulmonary emboli and pulmonary infarcts. Clin. Res. Proc 4, 257 (1956).

    Google Scholar 

  118. Sailer S.: Über die Wirkungsweise der Nicotinsäure auf Blutgerinnung und Fibrinolyse. Wien. Z. Inn. Med. 41, 307 (1960).

    Google Scholar 

  119. Sailer S., O. Eber: Über Thrombolyseversuche an Kaninchen mit einer kombinierten Nicotinsäure-Heparinbehandlung. Klin. Wschr. 38, 548 (1960).

    Google Scholar 

  120. Sandritter W., M. Huppert, G. Schlüter: Zur Frage der Fibrinolyse an experimentellen Gerinnungs- und Abscheidungsthromben. Klin. Wschr. 36, 651 (1958).

    Google Scholar 

  121. Sawyer W. D., A. P. Fletcher, N. Alkjaersig, S. Sherry: Studies on the thrombolytic activity of human plasma. J. clin. Invest. 39, 426 (1960).

    Google Scholar 

  122. Sgouris J. T., J. K. Inman, K. B. McCall: The preparation of human urokinase. Am. J. Card. 6, 406 (1960).

    Google Scholar 

  123. Sherry S., N. Alkjacrsig: Biochemical, experimental and clinical studies of proteolytic enzymes: with particulars reference to the fibrinolytic enzyme of human plasma. Ann. N. Y. Acad. Sci. 68, 52 (1957).

    Google Scholar 

  124. Sherry S., A. P. Fletcher: Proteolytic enzymes: a therapeutic evaluation. Clin. Pharm. Therap. 1, 202 (1960).

    Google Scholar 

  125. Sherry S., R. I. Lindemeyer, A. P. Fletcher, N. Alkjaersig: Studies on enhanced fibrinolytic activity in man. J. Clin. Invest. 38, 810 (1959).

    Google Scholar 

  126. Sokal J., S. Hecker, A. Johnson, R. Warren: The evaluation of clot lysing agents. Am. J. Card. 6, 552 (1960).

    Google Scholar 

  127. Soulier J. P., D. Alagille, M. J. Larrieu, O. Wartelle, C. Weilland: Modifications «in vivo» des facteurs de coagulation dans les fibrinolyse. Valeure du déficit en proaccelerin pour le diagnostic des protéolyses frustes ou latentes. Sem. Hop. Par. 32, 359 (1956).

    Google Scholar 

  128. Stacher A., J. Böhnel: Vergleichende Untersuchungen zwischen dem Streptokinaseresistenztest und einem thrombelastographischen Streptokinasetoleranztest. Schweiz. Med. Wschr. 91, 1143 (1961).

    Google Scholar 

  129. Stamm H., E. Eichenberger: Thromboemboliebehandlung mit Pyrexal. Gebh., Frauenh. 19, 451 (1958).

    Google Scholar 

  130. Steinmann B., H. J. Schafroth: Zur Nikotinsäurebchandlung cerebrovasculärer Erkrankungen, insbesondere der Haemiplegie. therap. Umschau. 16, 147 (1959).

    Google Scholar 

  131. Storm O.: Lysis of artificial thrombi by plasmin produced by activation with the urine activator. Dan. Med. Bull. 3, 179 (1956).

    Google Scholar 

  132. Sussmann B. J., T. S. P. Fitch: Thrombolysis with fibrinolysin in cerebral arterial occlusion. Angiology 12, 169 (1961).

    Google Scholar 

  133. Tapia F. A., H. Bolton, M. Mazel: Experimental acute coronary occlusion treated with fibrinolysin. Clin. Res. Proc. 8, 279 (1960).

    Google Scholar 

  134. Amery A., Verstract M., Maes H., Vermylen J. Over trombolytische therapie. Belg. Tijdschr. Geneesk. 1961, 899.

  135. Weiner M., K. De Crinis, W. Redisch, J. M. Steele: Influence of some vasoactive drugs on fibrinolytic activity. Circulation 19, 845 (1959).

    Google Scholar 

  136. Weiner M., W. Redisch, K. Dicrinis: The non emzymatic induction of fibrinolysis. p. 261, 7th. Congr. Europ. Soc. Haemat. 1959.

  137. Weiner M., W. Redisch, J. M. Steele: Occurrence of fibrinolytic activity following administration of nicotinic acid. Proc. Soc. exper. Biol. Med. 98, 755 (1958).

    Google Scholar 

  138. Westphal O., O. Lüderitz: Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66, 407 (1954).

    Google Scholar 

  139. Whitman N. L., Th. Shohl, W. F. Barker: Prevention of arterial thrombosis following experimental endarterectomy with plasmin. Ann. Surg. 153, 533 (1961).

    Google Scholar 

  140. Wilson W. L., G. Fostiropoulos: Observation on the use of nicotinic acid to induce fibrinolytic activity. Am. J. Med. Sci. 238, 591 (1959).

    Google Scholar 

Download references

Author information

Author notes

  1. E. Deutsch

    Present address: Zentralen Gerinnungslaboratorium der I. Medizinischen Universitätsklinik in Wien, Lazarettgasse 14, Wien

Authors and Affiliations

    Authors
    1. E. Deutsch
      View author publications

      You can also search for this author in PubMed Google Scholar

    Additional information

    Die Untersuchungen wurden mit Unterstützung der Blood Research Foundation, Washington, U. S. A., durchgeführt

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    Deutsch, E. Fortschritte der fibrinolytischen Therapie. Blut 7 (Suppl 1), 472–499 (1961). https://doi.org/10.1007/BF01636101

    Download citation

    • Received:

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF01636101

    Search

    Navigation